WO2014108100A1 - Intraocular lens - Google Patents

Intraocular lens Download PDF

Info

Publication number
WO2014108100A1
WO2014108100A1 PCT/CN2014/070528 CN2014070528W WO2014108100A1 WO 2014108100 A1 WO2014108100 A1 WO 2014108100A1 CN 2014070528 W CN2014070528 W CN 2014070528W WO 2014108100 A1 WO2014108100 A1 WO 2014108100A1
Authority
WO
WIPO (PCT)
Prior art keywords
intraocular lens
optical body
lens
iris
front surface
Prior art date
Application number
PCT/CN2014/070528
Other languages
French (fr)
Chinese (zh)
Inventor
王清扬
齐备
Original Assignee
Wang Qingyang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wang Qingyang filed Critical Wang Qingyang
Publication of WO2014108100A1 publication Critical patent/WO2014108100A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1602Corrective lenses for use in addition to the natural lenses of the eyes or for pseudo-phakic eyes
    • A61F2/161Posterior chamber lenses for use in addition to the natural lenses of the eyes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1601Lens body having features to facilitate aqueous fluid flow across the intraocular lens, e.g. for pressure equalization or nutrient delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2002/1681Intraocular lenses having supporting structure for lens, e.g. haptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Fluid Mechanics (AREA)
  • Physics & Mathematics (AREA)
  • Prostheses (AREA)

Abstract

Disclosed is an intraocular lens (10), comprising an optical body (30) and a support body (20). The optical body (30) and the support body (20) have a front and a rear surface. A plurality of projections (40) are provided at the support body (20) near the edge of the optical body (30) at the front surface of the intraocular lens (10). After locating the intraocular lens (10) in the posterior chamber (110), the plurality of projections (40) are in contact with the iris (140). An additional space is formed between the front surface of the intraocular lens (10) and the iris (140) at least around the projections (40), wherein the space adds a passage for the aqueous humour; and the aqueous humour of the posterior chamber (110) enters the anterior chamber (100) from the additional passage by bypassing the intraocular lens (10) so as to maintain the normal intraocular pressure.

Description

眼内透镜  Intraocular lens
技术领域 Technical field
本发明涉及一种眼内透镜 (IOL ) 。 更具体地说, 本发明涉及一 种可以植入眼睛内、 与眼睛的自然晶状体共同存在, 能够用以矫正眼 屈光误差的眼内透镜。 背景技术  The present invention relates to an intraocular lens (IOL). More specifically, the present invention relates to an intraocular lens that can be implanted in the eye and coexist with the natural lens of the eye to correct eye refractive error. Background technique
本申请人于 2003年 2月 21 日提交了题为 《眼内屈光透镜及其 植入方法》 的发明专利, 申请号为 03115498.0, 公开号为 The applicant submitted the invention patent entitled "Intraocular refractive lens and its implantation method" on February 21, 2003. The application number is 03115498.0, and the publication number is
CN1466934A, 在此以非限定的方式全文引用并入本申请, 以方便对 本发明的理解。 The present application is hereby incorporated by reference in its entirety in its entirety in its entirety in its entirety in its entirety herein
近年来, 随着眼科显微手术技巧的日臻完善、 眼内透镜 (人工晶 状体) 植入术的普及和提高, 采用后房型人工晶状体植入, 不仅更容 易保持适当的生理位置, 还可避免前房型人工晶状体的远期并发症。 关于将眼内透镜置于眼后房的方案, 通常包括以下两种情况: 1 ) 没有 摘除囊袋中的自然晶状体, 将眼内透镜置于自然晶状体前侧共同作用 调整眼的屈光度; 2) 摘除自然晶状体, 并且置入眼内透镜, 从而用人 工晶状体替代原有的自然晶状体, 例如在治疗白内障的手术中。  In recent years, with the improvement of ophthalmic microsurgery techniques and the popularization and improvement of intraocular lens (intraocular lens) implantation, posterior chamber intraocular lens implantation is not only easier to maintain proper physiological position, but also avoids the former. Long-term complications of atrial intraocular lens. The scheme of placing the intraocular lens in the posterior chamber of the eye usually includes the following two situations: 1) without removing the natural lens in the capsular bag, placing the intraocular lens on the anterior side of the natural lens to adjust the diopter of the eye; 2) The natural lens is removed and placed in the intraocular lens to replace the original natural lens with an intraocular lens, for example in the treatment of cataract.
由于眼部生理结构的精密性,上述技术仍然需要不断完善和改进, 从而进一步减小手术引发的副作用, 并提高眼内透镜与生物体本身的 相容性和配合度。  Due to the precision of the physiological structure of the eye, the above techniques still need to be continuously improved and improved, thereby further reducing the side effects caused by the surgery and improving the compatibility and fit of the intraocular lens with the living body itself.
在本领域中, 在眼后房植入眼内透镜, 如果原来的自然晶状体仍 然存在, 则需要重建房水循环。 如何有效重建房水循环仍然是本领域 中期待有效改善的一个重要方面。  In the art, an intraocular lens is implanted in the posterior chamber of the eye, and if the original natural lens still exists, it is necessary to reconstruct the aqueous humor cycle. How to effectively rebuild the aqueous water cycle is still an important aspect in the field that is expected to improve effectively.
据知, 本领域已有相关的改善措施。 例如, STAAR® Surgical Company 提出了对植入眼后房的眼内透镜打孔的技术, 该孔要定位于 瞳孔的后方。 但是, 定位于瞳孔后方的孔不得不设置于眼内透镜的光 学体部分, 因此, 容易对透镜的屈光性能产生影响。 另外一个可能的 问题是, 眼内透镜设置于靠近瞳孔的部位是承受压力最高的部位, 因 此, 该部位容易与虹膜贴靠到一起, 在瞳孔收缩过程中, 虹膜与人工 晶状体的接触致少许虹膜色素脱落, 可能会由虹膜造成小孔封堵。 It is known that there are related improvement measures in the field. For example, STAAR® Surgical Company has proposed a technique for perforating an intraocular lens implanted in the posterior chamber of the eye, which is positioned behind the pupil. However, the hole positioned behind the pupil has to be placed in the optical body portion of the intraocular lens, and therefore, it is easy to affect the refractive performance of the lens. Another possible problem is that the intraocular lens is placed near the pupil and is the site with the highest pressure. Therefore, the part is easy to abut with the iris. During the pupil contraction, the contact between the iris and the intraocular lens causes a little iris pigment to fall off, which may cause small pores to be blocked by the iris.
本领域还提出了另外一种减少房水排出阻力的方法, 即, 在虹膜 Another method for reducing the discharge resistance of aqueous humor is also proposed in the art, namely, in the iris.
( iris ) 上打孔, 例如, 杭州百康医用技术有限公司的 PC-PRL 和 STAAR® Surgical Company的 ICL都采用了在手术前或手术过程中在 虹膜周做切口, 利用虹膜切口提供辅助的房水流通通道, 从而帮助重 建房水循环通道。 这种方法仍然存在缺点, 首先, 这种方法会增加手 术造成的创伤, 目前还难以预期这种创伤带来的远期影响。 另外, 由 于虹膜表面含有较多的色素, 打孔容易造成色素脱落。 色素脱落带来 的影响可能导致增加继发性高眼压、 青光眼等发生的风险。 此外, 翻 起上眼睑, 可以从眼外部观察到虹膜上的切口残留的孔, 也会一定程 度地影响眼部的美观。 Perforation on (iris), for example, PC-PRL of Hangzhou Baikang Medical Technology Co., Ltd. and ICL of STAAR® Surgical Company have used incision in the iris circumference before or during surgery, and assisted rooms with iris incision The water circulation channel helps to reconstruct the circulation channel of the aqueous water. This method still has shortcomings. First, this method will increase the trauma caused by surgery, and it is difficult to predict the long-term effects of this trauma. In addition, since the surface of the iris contains a large amount of pigment, the punching is likely to cause the pigment to fall off. The effects of pigment shedding may increase the risk of secondary high intraocular pressure, glaucoma, and the like. In addition, when the upper eyelid is turned up, the remaining hole in the iris can be observed from the outside of the eye, which also affects the appearance of the eye to a certain extent.
为解决上述现有技术中存在的问题,本发明提出了新的改进方案。 发明内容  In order to solve the above problems in the prior art, the present invention proposes a new improvement. Summary of the invention
因此, 本发明目的在于提供一种改进的眼内透镜, 用于改善人工 晶状体植入术后的房水循环。 本发明的改进是通过直接改进眼内透镜 的前表面结构, 并且避免传统方式通过外科创伤来改善房水循环。 通 过本发明, 期望消除或减轻眼内透镜植入术后对房水循环的影响。  Accordingly, it is an object of the present invention to provide an improved intraocular lens for improving aqueous humor circulation after intraocular lens implantation. The improvement of the present invention is to improve the anterior surface structure of the intraocular lens and to avoid the improvement of the aqueous humor cycle by surgical trauma in a conventional manner. With the present invention, it is desirable to eliminate or reduce the effects of intraocular lens implantation on aqueous humor circulation.
本发明的第一方面提供一种眼内透镜, 其包括光学体和支撑体, 光学体和支撑体具有前表面和后表面, 其中, 于眼内透镜的前表面, 在靠近所述光学体边缘的支撑体处设置多个凸起。  A first aspect of the invention provides an intraocular lens comprising an optical body and a support body, the optical body and the support body having a front surface and a rear surface, wherein the front surface of the intraocular lens is adjacent to the edge of the optical body A plurality of protrusions are provided at the support body.
上述第一方面提供了如下的技术效果: 于眼内透镜的前表面, 在 靠近所述光学体边缘的支撑体处设置多个凸起, 眼内透镜植入眼后房 之后, 多个凸起会与虹膜的后表面接触, 至少在凸起的周围使得眼内 透镜的前表面与虹膜的后表面之间产生附加的间隙, 由此, 这些间隙 增加了房水的通道, 眼后房的房水可以绕过眼内透镜从附加的通道流 向瞳孔, 并进入眼前房。  The above first aspect provides the following technical effects: on the front surface of the intraocular lens, a plurality of protrusions are disposed at a support body near the edge of the optical body, and the plurality of protrusions are implanted after the intraocular lens is implanted in the posterior chamber of the eye. Will contact the back surface of the iris, at least around the protrusion to create an additional gap between the front surface of the intraocular lens and the posterior surface of the iris, thereby increasing the passage of the aqueous humor, the chamber of the posterior chamber of the eye Water can bypass the intraocular lens from the additional channel to the pupil and into the anterior chamber of the eye.
根据本发明的第二方面, 所提供的眼内透镜上设置的凸起与眼内 透镜一体成型, 并且该凸起具有光滑的曲面。 优选地, 该凸起为从所 述眼内透镜前表面突出的半球形。 According to the second aspect of the present invention, the projection provided on the intraocular lens is integrally formed with the intraocular lens, and the projection has a smooth curved surface. Preferably, the protrusion is from A hemispherical shape in which the front surface of the intraocular lens protrudes.
凸起的光滑表面和半球形设计可以最小化凸起对虹膜的机械刺 激, 以及避免妨碍或干扰瞳孔的运动。 透镜的凸起设置, 可以通过在 现有的透镜加工模具的对应位置处增设凹坑形成, 因此, 凸起的半球 形设计对于透镜模具的加工制造也更为便利。  The raised smooth surface and hemispherical design minimizes the mechanical stimuli of the embossment on the iris and avoids obstructing or disturbing the movement of the pupil. The convex arrangement of the lens can be formed by adding pits at corresponding positions of the existing lens processing mold, and therefore, the convex hemispherical design is more convenient for the processing of the lens mold.
根据本发明的另外一方面提供的眼内透镜, 其中的半球形直径为 0.3 ~ 0.5mm。  According to another aspect of the present invention, there is provided an intraocular lens having a hemispherical diameter of 0.3 to 0.5 mm.
进一步, 根据本发明上述方面的眼内透镜, 其中多个凸起以能够 为眼内透镜提供稳定支撑的方式围绕所述光学体分开布置。  Further, an intraocular lens according to the above aspect of the invention, wherein the plurality of protrusions are arranged separately around the optical body in a manner capable of providing stable support for the intraocular lens.
进一步, 根据本发明上述方面的眼内透镜, 其中共设置 4个凸起, 相对于所述光学体以上下对称且左右对称的方式分开布置。  Further, according to the intraocular lens of the above aspect of the invention, a total of four protrusions are provided, which are arranged separately from each other in a manner of being symmetrical and bilaterally symmetrical with respect to the optical body.
进一步, 根据本发明上述方面的眼内透镜, 其中共设置 6个凸起, 相对于所述光学体以上下对称且左右对称的方式分开布置。  Further, according to the intraocular lens of the above aspect of the invention, a total of six projections are provided, which are arranged separately from each other in a manner of being vertically symmetrical and bilaterally symmetrical with respect to the optical body.
此外, 优选本发明眼内透镜的材料为软性材料, 其比重与房水比 重一致。  Further, it is preferred that the material of the intraocular lens of the present invention is a soft material having a specific gravity which is consistent with the specific gravity of the aqueous humor.
另外一方面, 本发明也适用于眼内透镜中的光学体具有其他的形 状的情况, 例如, 光学体设置为大致椭圆形状, 其长轴设置于水平方 向, 以及短轴设置于竖直方向。 通过此方案, 可以有效克服从瞳孔两 侧进入的眩光。  On the other hand, the present invention is also applicable to the case where the optical body in the intraocular lens has other shapes, for example, the optical body is disposed in a substantially elliptical shape, the long axis thereof is disposed in the horizontal direction, and the short axis is disposed in the vertical direction. Through this scheme, the glare entering from both sides of the pupil can be effectively overcome.
本发明的设计, 避免常规技术需要做至少 1个虹膜周切口 (手术 带来的损伤) , 以在植入眼内透镜后使眼内房水能正常循环。 附图说明  The design of the present invention avoids the need for at least one iris peri-incision (surgical injury) to avoid normal circulation of intraocular water after implantation of the intraocular lens. DRAWINGS
下面结合附图和实施例对本发明进一步说明。  The invention will now be further described with reference to the drawings and embodiments.
图 1是示意性剖视图, 示出根据本发明第一实施例的有晶体眼的 眼内透镜植入于眼后房位置;  1 is a schematic cross-sectional view showing a lensed intraocular lens implanted in a posterior chamber position according to a first embodiment of the present invention;
图 2是图 1所示眼内透镜的示意性俯视图;  Figure 2 is a schematic plan view of the intraocular lens of Figure 1;
图 3是沿图 2中 A-A线所取的眼内透镜的剖视示意图;  Figure 3 is a cross-sectional view of the intraocular lens taken along line A-A of Figure 2;
图 4为示意性剖视图, 示出与本发明对照的比较例的眼内透镜植 入眼后房位置; 图 5是图 4所示眼内透镜比较例的俯视示意图; Figure 4 is a schematic cross-sectional view showing the intraocular lens of the comparative example of the comparative example of the present invention implanted in the posterior chamber; Figure 5 is a top plan view of a comparative example of the intraocular lens shown in Figure 4;
图 6是图 5所示眼内透镜比较例的剖视示意图;  Figure 6 is a cross-sectional view showing a comparative example of the intraocular lens shown in Figure 5;
图 7是根据本发明第二实施例的眼内透镜的俯视示意图  7 is a top plan view of an intraocular lens according to a second embodiment of the present invention.
图 8是根据本发明第三实施例的眼内透镜的俯视示意图  Figure 8 is a top plan view of an intraocular lens according to a third embodiment of the present invention.
图 9是根据本发明第四实施例的眼内透镜的俯视示意图  9 is a top plan view of an intraocular lens according to a fourth embodiment of the present invention.
图 10示出眼球的水平切面图。 具体实施方式  Figure 10 shows a horizontal cutaway view of the eyeball. detailed description
虽然为了清楚起见在下文描述中使用了特定术语, 这些术语仅 涉及用于说明附图中所选择实施方式的特定结构,不应当理解为用于 限定或限制本发明的范围。在附图和下文描述中, 可以理解同样的附 图标记指同样的功能组件。  The specific terminology used in the following description is for the purpose of clarity, and is not intended to limit or limit the scope of the invention. In the drawings and the following description, the same reference numerals are used to refer to the same.
与数量结合使用的修饰语 "约" 包括所列数值并且具有由上下 文指定的含义(例如,其至少包括与特定数量的测量相关的误差度)。  The modifier "about" used in connection with a quantity includes the recited value and has the meaning specified by the context (e.g., it includes at least the degree of error associated with a particular number of measurements).
[常用术语的定义] [Definition of commonly used terms]
为了方便理解本发明, 首先对以下术语提供解释或定义: 自然晶状体: 是指人类(或广指哺乳动物) 眼睛内的自然晶状体。 自然晶状体外面包有一层弹性的膜囊, 也称囊袋。 本发明中提到的在 自然晶状体表面上, 是指在自然晶状体前表面的膜囊上。 自然晶状体 是透明的并能调节聚焦能力, 其能使近 (或远) 距离的物体落在视网 膜上成像。 从 40岁开始, 大多数人的这种调节聚焦能力开始衰退, 至 50岁左右开始完全丧失这种调节聚焦能力,这就是我们所说的老花眼。  To facilitate an understanding of the present invention, the following terms are first explained or defined: Natural lens: refers to the natural lens in the eye of a human (or broadly referred to as a mammal). Natural crystalline in vitro bread has a layer of elastic membrane sac, also known as a capsular bag. As referred to in the present invention, on the surface of the natural lens, it refers to the film capsule on the front surface of the natural lens. The natural lens is transparent and adjusts the ability to focus, allowing objects near (or far) distance to be imaged on the retina. Since the age of 40, most of these people's ability to adjust their focus has begun to decline. By the age of 50, they have completely lost this ability to adjust and focus. This is what we call presbyopia.
本发明所说的眼内透镜, 也称眼内屈光透镜、 屈光透镜, 是指植 入人类 (或泛指哺乳动物) 眼内与自然晶状体同时存在并同时起作用 来纠正视力屈光误差的光学镜片。 眼内透镜由一个光学体和支撑体组 成。  The intraocular lens, also called the intraocular refractive lens and the refractive lens, refers to the simultaneous presence and simultaneous action of the implanted human (or generally mammalian) eye and the natural lens to correct the visual refractive error. Optical lens. The intraocular lens consists of an optical body and a support.
光学体: 是指眼内屈光透镜的中心组成部分, 可以是双凸镜, 双 凹镜, 前凹后凸镜或前凸后凹镜。 光学体用来使入射光束聚集到视网 膜上, 它的屈光度常用 D来表示。 如, -1D就是常说的近视 100度, +1D就是常说的远视 100度。 Optical body: refers to the central component of the intraocular refractive lens, which can be a double convex mirror, a double concave mirror, a front concave convex convex mirror or a front convex back concave mirror. The optical body is used to concentrate the incident beam onto the retina, and its diopter is usually represented by D. For example, -1D is often said to be 100 degrees of myopia, +1D is often said to be 100 degrees farsighted.
支撑体: 也称 "襻部" , 其直接与光学体相连接, 其不提供屈光 调整的功能, 而是用于承载光学区域, 用来支撑光学体在眼中理想中 心位置。 植入后房的眼内透镜, 其光学区位于瞳孔后, 而支撑体位于 虹膜后表面。  Support: Also known as the "ankle", it is directly connected to the optical body. It does not provide the function of refractive adjustment, but is used to carry the optical area to support the ideal center position of the optical body in the eye. In the intraocular lens implanted in the posterior chamber, the optical zone is located behind the pupil, and the support is located on the posterior surface of the iris.
角膜: 眼睛前部透明的曲面型组织。  Cornea: A transparent, curved tissue at the front of the eye.
虹膜: 角膜后面的环形色素膜, 中央为瞳孔。  Iris: A ring of pigmented membrane behind the cornea with a pupil in the center.
睫状小带: 或简称小带, 指粘在自然晶状体赤道周围睫状小带。 也称睫状体。  The ciliary zonule: or simply a small band, refers to a small zonule that sticks around the equator of the natural lens. Also known as the ciliary body.
瞳孔 (pupil) : 是虹膜中央部位的圆形缺损, 可散大和縮小, 以 调节光线进入眼球的多少。  Pupil: A circular defect in the center of the iris that can be enlarged and reduced to adjust how much light enters the eye.
眼前房: 位于角膜和虹膜之间的空间位置。  Anterior chamber: A spatial location between the cornea and the iris.
眼后房: 泛指位于虹膜后面的空间位置。 在本发明的说明书中, 常指位于在虹膜后面和自然晶状体前面的空间位置。 虹膜既不属于前 房, 又不属于后房, 而是作为区分前、 后房的分界。  Posterior chamber: Refers to the spatial location behind the iris. In the context of the present invention, it is often referred to as a spatial location located behind the iris and in front of the natural lens. The iris is neither part of the anterior chamber nor the posterior chamber, but serves as a boundary between the front and the back.
小刀切口: 白内障手术外科医生常用术语。 一般指在角膜上或边 缘切开约 3毫米长的切口, 一个约 6毫米直径的人工晶状体在折叠后 可以植入该切口。 这种手术在一般情况下, 不需缝线, 伤口会自愈。  Knife Incision: A term commonly used by surgeons in cataract surgery. Generally, an incision of about 3 mm in length is made on the cornea or on the edge, and an intraocular lens of about 6 mm in diameter can be implanted into the incision after folding. In general, this type of surgery does not require sutures and the wound will heal itself.
下面, 参考附图进一步描述本发明的技术方案, 提供附图是为 了帮助理解本文所披露的装置构成, 以更完整地理解本发明。提供附 图仅仅是为了方便说明, 并且附图皆为示意性图示, 因此, 并不意图 指示装置或其组成部件的相对大小及尺寸和 /或限定或限制实施例的 范围。  The technical solutions of the present invention are further described below with reference to the accompanying drawings, which are to provide a more complete understanding of the present invention. The drawings are provided for illustrative purposes only and are not intended to indicate the relative size and size of the device or its components and/or to limit or limit the scope of the embodiments.
关于方向描述的说明: 文中提到的水平方向或左右方向, 是指 眼睛或者人眼的左右方向, 文中提到的上下方向, 是指眼睛或者人眼 的上下方向。 为方便理解本发明,在此提供附图 10,其示出典型的眼球切面图。 参考附图 10介绍关于正常的房水循环体系。  Explanation of the direction description: The horizontal direction or the left and right direction mentioned in the text refers to the left and right direction of the eyes or the human eye. The up and down direction mentioned in the text refers to the up and down direction of the eyes or the human eye. To facilitate an understanding of the present invention, FIG. 10 is provided herein which shows a typical eye cutaway view. Refer to Figure 10 for a description of the normal aqueous circulation system.
眼房包括前房 100、 后房 110和玻璃体腔 121 (其中容纳玻璃体 120) 。 The eye chamber includes the anterior chamber 100, the posterior chamber 110, and the vitreous chamber 121 (which houses the vitreous body) 120).
前房 ( anterior chamber) 100, 位于角膜 130之后、 虹膜 140和晶 状体 150的瞳孔区之前, 其周边是由角膜缘 160、 睫状体 170及虹膜根 部共同组成的夹角, 称为前房角 280, 是房水循环的关键部位。  An anterior chamber 100, located behind the cornea 130, before the pupil region of the iris 140 and the lens 150, is surrounded by an angle formed by the limbus 160, the ciliary body 170, and the iris root, which is called the anterior chamber angle 280. , is a key part of the aqueous circulation.
后房 (posterior chamber) 110, 位于虹膜 140及瞳孔 180之后、 晶状体 150 及悬韧带和睫状突之前的间隙内。 后房的前界为虹膜后面 的色素上皮; 前侧界为虹膜和睫状体的连接部; 侧界为具有睫状突和 突间凹的睫状冠; 真正的后界为玻璃体前界膜。 后房的容积狭小, 形 状不规则,为房水所填充。后房间隙的大小受眼的调节( accommodation ) 因素的影响, 在眼使用调节时, 晶状体 150 向前凸起, 后房 110即变 窄; 在调节静止的状态下, 晶状体 150恢复原有的形状, 后房 110又 变宽。  A posterior chamber 110, located behind the iris 140 and the pupil 180, in the gap between the lens 150 and the suspensory ligament and the ciliary process. The posterior border of the posterior chamber is the pigment epithelium behind the iris; the anterior border is the junction of the iris and the ciliary body; the border is the ciliary crown with ciliary processes and intersegmental recesses; the true posterior border is the vitreous anterior membrane . The back room has a small volume and an irregular shape, which is filled with water. The size of the posterior chamber space is affected by the accommodation factor of the eye. When the eye is adjusted, the lens 150 is convex forward, and the posterior chamber 110 is narrowed. In the state of being adjusted to rest, the lens 150 is restored to its original shape. The rear room 110 is widened again.
在后房 110的固有部 (proper part of posterior chamber) 、 虹膜根 部与睫状突之间有一浅沟, 称为睫状沟 (ciliary sulcus ) 。 此沟的直径 与角膜的直径相近似。 睫状沟在巩膜 190 表面的解剖学定位, 在临床 上具有重要的意义。  There is a shallow groove between the propor part of the posterior chamber, the root of the iris and the ciliary process, called the ciliary sulcus. The diameter of this groove is similar to the diameter of the cornea. The anatomical location of the ciliary sulcus on the surface of the sclera 190 is clinically important.
此外, 图 10中还示出了眼部的一些主要结构, 包括: 脉络膜 200, 视网膜 210, Cloquct管 220, 视乳头 230, 视神经 240, 巩膜筛板 250, 黄斑中央凹 260, 锯齿缘 270, 光轴 C, 视轴 B, 几何赤道 XI, 以及解 剖赤道 X2。  In addition, some major structures of the eye are also shown in FIG. 10, including: choroid 200, retina 210, Cloquct tube 220, optic papilla 230, optic nerve 240, scleral screen 250, macular fovea 260, serrated 270, light Axis C, boresight B, geometric equator XI, and anatomical equator X2.
前后房充满房水。 房水由睫状突上皮产生, 首先进入后房, 经瞳 孔流入前房,然后经前房的小梁网及 Schlemm管排出眼外进入血循环。 少量的房水会被吸收或进入视神经周围的淋巴循环等。 正常情况下, 房水的生成与排出保持动态平衡。  The front and rear rooms are filled with water. The aqueous humor is produced by the ciliary process epithelium, first entering the posterior chamber, flowing into the anterior chamber through the pupil, and then exiting the blood circulation through the trabecular meshwork of the anterior chamber and the Schlemm tube. A small amount of aqueous humor will be absorbed or enter the lymphatic circulation around the optic nerve. Under normal circumstances, the formation and discharge of aqueous humor maintains a dynamic balance.
房水 (aqueous humor) 是无色透明的液体, 其容量为 0.25〜0.30 毫升, 前房约 0.18毫升, 后房约 0.06毫升。 房水来自血浆, 化学成分 与血浆相似, 主要成分为水, 蛋白质的含量较血浆明显减少, 但维生 素 0、 Na+、 Cr等含量比血浆高。 房水的生理功能是为角膜、 晶状体及 前段玻璃体提供营养并维持正常眼压。  The aqueous humor is a colorless, transparent liquid with a capacity of 0.25 to 0.30 ml, an anterior chamber of about 0.18 ml, and a posterior chamber of about 0.06 ml. The aqueous humor comes from plasma, and its chemical composition is similar to that of plasma. The main component is water. The protein content is significantly lower than that of plasma, but the content of vitamins 0, Na+ and Cr is higher than that of plasma. The physiological function of aqueous humor is to provide nutrients for the cornea, lens and anterior segment of the vitreous and maintain normal intraocular pressure.
由于人工晶状体即眼内透镜的植入, 特别是植入后房的人工晶状 体, 容易在房水排出系统中产生额外的阻力。 例如, 当人工晶状体置 于瞳孔后方, 可能造成虹膜与晶体表面的接触面增加、 贴紧, 使得房 水由后房流向前房的阻力增加, 甚至引起房水流动方向改变为从前房 到后房。 如果不能有效消除对房水排出系统的阻力, 则会带来临床上 的不良后果, 例如眼压升高或青光眼等。 本发明的目的在于改进现有眼内透镜本身的结构, 更具体而言, 改变眼内透镜的前表面结构或构造。 具体涉及植入眼后房眼内透镜, 这种眼内透镜与眼睛的自然晶状体共同存在, 能够用以矫正眼屈光误 差。 Due to the implantation of the intraocular lens, the intraocular lens, especially the intraocular lens implanted in the posterior chamber Body, it is easy to generate extra resistance in the aqueous drainage system. For example, when the intraocular lens is placed behind the pupil, the contact surface between the iris and the crystal surface may increase and close, so that the resistance of the aqueous humor from the posterior chamber to the front chamber increases, and even the direction of the aqueous humor changes from the anterior chamber to the posterior chamber. . If the resistance to the aqueous drainage system is not effectively eliminated, it will have clinically undesirable consequences, such as elevated intraocular pressure or glaucoma. It is an object of the present invention to improve the structure of an existing intraocular lens itself, and more particularly to change the front surface structure or configuration of an intraocular lens. Specifically, it relates to an intraocular lens implanted in the posterior chamber of the eye. This intraocular lens coexists with the natural lens of the eye and can be used to correct the refractive error of the eye.
请参见附图 1-3和图 7-9, 示出本发明的实施例。 本发明涉及的眼 内透镜 10包括布置于眼内透镜 10中部的光学体 30和布置于光学体 30 周围用于承载光学体 30的支撑体 20。  Referring to Figures 1-3 and Figures 7-9, an embodiment of the present invention is illustrated. The intraocular lens 10 according to the present invention includes an optical body 30 disposed in the middle of the intraocular lens 10 and a support body 20 disposed around the optical body 30 for carrying the optical body 30.
由于眼球内不论是前房 100还是后房 1 10均充满水状液, 当眼内 透镜 10植入后, 它的后表面基本上依附在自然晶状体 150的前表面。 由于眼内的水状液是从后房 1 10通过瞳孔 180流向前房 100,这种水状 液的流动使得夹在眼内透镜 10和自然晶状体 150之间的薄水层得到不 断的补充和取代更新。  Since both the anterior chamber 100 and the posterior chamber 1 10 are filled with aqueous liquid in the eyeball, when the intraocular lens 10 is implanted, its posterior surface is substantially attached to the front surface of the natural lens 150. Since the aqueous liquid in the eye flows from the posterior chamber 10 through the pupil 180 to the front chamber 100, the flow of the aqueous liquid is such that the thin water layer sandwiched between the intraocular lens 10 and the natural lens 150 is continuously replenished and Replace the update.
本发明的关键在于改变眼内透镜 10的前表面的结构,具体为改变 支撑体 20部分的前表面结构, 在靠近所述光学体边缘的支撑体 20处 设置多个凸起 40。 这些凸起 40具有丘状体形状, 其底部设置于透镜支 撑体 20的本体部, 由支撑体 20的前表面凸出。 这些凸起与透镜本身 一体成形, 在制造透镜模具时设置对应的凹部, 即可通过注塑成形等 获得透镜以及其上的丘状体结构。  The key to the present invention is to change the structure of the front surface of the intraocular lens 10, specifically to change the front surface structure of the portion of the support body 20, and to provide a plurality of protrusions 40 at the support body 20 near the edge of the optical body. These projections 40 have a shape of a mound, and the bottom portion thereof is provided at the body portion of the lens supporting body 20, and is protruded from the front surface of the support body 20. These projections are integrally formed with the lens itself, and corresponding recesses are provided at the time of manufacturing the lens mold, and the lens and the moire structure thereon can be obtained by injection molding or the like.
当将眼内透镜 10置于眼后房 1 10定位后, 凸起 40会与虹膜 140 的后表面接触, 即, 对虹膜 140提供支撑, 从而在凸起 40的周围形成 适当的间隙以构成附加的房水流通通道。 优选地, 凸起 40表面光滑, 最好为光滑的曲面。 更优选地, 凸起为从所述眼内透镜前表面突出的 半球形。 凸起 40表面形状的设计, 基于与虹膜 140之间相互作用的考 虑。 凸起 40的光滑表面会尽量减少对虹膜的机械刺激, 进一步, 随着 瞳孔 (pupil) 的放大和缩小, 虹膜 140会在凸起 40的表面 "爬行" 。 因此, 凸起 40的光滑表面能够避免妨碍或干扰瞳孔的运动。 When the intraocular lens 10 is placed in the posterior chamber of the eye, the projection 40 will contact the rear surface of the iris 140, i.e., provide support to the iris 140, thereby forming a suitable gap around the projection 40 to constitute an additional Water circulation channel. Preferably, the projection 40 has a smooth surface, preferably a smooth curved surface. More preferably, the protrusion is a hemisphere protruding from the front surface of the intraocular lens. The design of the surface shape of the projections 40 is based on considerations of interaction with the iris 140. The smooth surface of the projection 40 minimizes mechanical irritation to the iris, further, When the pupil is enlarged and reduced, the iris 140 "crawls" on the surface of the projection 40. Therefore, the smooth surface of the projection 40 can avoid obstructing or disturbing the movement of the pupil.
在优选的实施方式中, 凸起设置为半球形。 半球形状的凸起适合 提供光滑的支撑,同时,从各方向都会减少对于虹膜 140 "爬行" 干扰。  In a preferred embodiment, the projections are arranged in a hemispherical shape. The hemispherical shaped projections are suitable for providing smooth support while reducing the "crawling" interference of the iris 140 from all directions.
进一步, 以半球形凸起为例描述凸起的尺寸设置。 半球形的凸起 的直径设置为大约 0.3mm至 0.5mm, 高度为半球形的半径。 当然, 根 据材料的挠性或具体应用的考虑, 可以适当调整具体的尺寸。  Further, the size setting of the protrusion is described by taking a hemispherical protrusion as an example. The diameter of the hemispherical projection is set to be about 0.3 mm to 0.5 mm, and the height is a hemispherical radius. Of course, the specific dimensions can be appropriately adjusted depending on the flexibility of the material or the specific application.
本发明并不特别限定凸起的数量。 例如, 可以设置 3个凸起 40, 4个凸起 40, 6个凸起 40等等。 凸起 40的数量设置主要考虑提供支撑 的稳定性, 以及, 在将眼内透镜植入虹膜后方, 凸起 40与虹膜 140接 触后在虹膜 140和透镜 10主体之间提供间隙的情况。  The invention does not particularly limit the number of protrusions. For example, three projections 40, four projections 40, six projections 40, and the like can be provided. The number of projections 40 is set primarily to provide stability to the support, and to provide a gap between the iris 140 and the body of the lens 10 after the projection 40 is placed in contact with the iris 140 after the intraocular lens is implanted behind the iris.
多个凸起以能够为眼内透镜提供稳定支撑的方式围绕光学体分开 布置, 意图使该多个凸起共同对眼内透镜提供稳定的平面式支撑, 以 及提供期望的间隙供房水流通。  The plurality of projections are spaced apart about the optical body in a manner that provides stable support for the intraocular lens, with the intention of providing the plurality of projections together to provide stable planar support to the intraocular lens and to provide a desired gap for aqueous humor to circulate.
本发明不希望具体限定眼内透镜的材料, 现有的多种不同材料 制成的眼后房透镜皆可根据本发明进行改进。 这类材料中更好的是具 有弹性和形状记忆性能、 在使用温度范围内呈弹性状态的材料, 包括 (但不局限于) 软聚丙烯酸酯类、 硅橡胶类、 凝胶类、 和其他高分子 软材料。  The present invention is not intended to specifically define the material of the intraocular lens, and existing ocular posterior lenses made of a variety of different materials can be modified in accordance with the present invention. Among these materials, materials having elastic and shape memory properties and being elastic in the temperature range of use include, but are not limited to, soft polyacrylates, silicone rubbers, gels, and others. Molecular soft materials.
可用于生产本发明的眼内透镜的聚合物的例子也可从下述专利 文献中获知, 所述专利文献为: 2001年 8月 7日公开的 Liao等人的 美国专利 6,271,281 ; 2002年 8月 13 日公开的 Nanushyan等人的美国 专利 6,432, 137; 2004 年 8 月 24 日公开的 Liao 等人的美国专利 6,780,899; 2004年 1月 20日公开的 Zhou 等人的美国专利 6,679,605 ; 以及 1995年 8月 22 日公开的 Zhou 等人的美国专利 5,444,106, 所 有这些专利文献均以引用方式并入本文。这些例子均得自于有机硅胶 类和丙烯酸类的聚合物。 其它可用的疏水性聚合物的例子包括聚烯 烃, 例如具有挠性的弹性聚合物网络的苯乙烯-丁二烯共聚物和苯乙 烯 -异戊二烯共聚物。  An example of a polymer that can be used to produce the intraocular lens of the present invention is also known from the following patent documents: U.S. Patent 6,271,281, issued to Liao et al., issued Aug. 7, 2001; U.S. Patent No. 6,432, 137 to Lanushyan et al., issued on Aug. 13; U.S. Patent No. 6,780,899, issued to Aug. 24, 2004; U.S. Patent No. 6,679,605, issued to Jan et al. U.S. Patent No. 5,444,106, the disclosure of which is incorporated herein by reference. These examples are derived from polymers of silicones and acrylics. Examples of other useful hydrophobic polymers include polyolefins such as styrene-butadiene copolymers and styrene-isoprene copolymers having a flexible elastomeric polymer network.
本发明的要旨在于改进现有眼内透镜的前表面结构, 因此, 根 据本发明可以基于现有眼内透镜提出改进的方案。 实施例 The present invention is directed to improving the front surface structure of an existing intraocular lens, and therefore, According to the present invention, an improved solution can be proposed based on existing intraocular lenses. Example
下面, 参照实施例具体描述根据本发明的眼内透镜的结构改进。 第一实施例  Next, structural improvements of the intraocular lens according to the present invention will be specifically described with reference to the embodiments. First embodiment
请参见附图 1-3,示出的实施例为一种植入眼后房位置的有晶体眼 的眼内透镜。 图 1 为示意性剖视图, 示出根据本发明第一实施例的有 晶体眼的眼内透镜植入眼后房位置; 图 2 是本实施例眼内透镜的示意 性俯视图; 图 3是沿图 2中 A-A线所取的本实施例眼内透镜的示意性 剖视图。  Referring to Figures 1-3, the illustrated embodiment is a phakic intraocular lens implanted in the posterior chamber of the eye. 1 is a schematic cross-sectional view showing an intraocular lens with a lens eye implanted in a posterior chamber position according to a first embodiment of the present invention; FIG. 2 is a schematic plan view of the intraocular lens of the present embodiment; A schematic cross-sectional view of the intraocular lens of the present embodiment taken in line 2 of AA.
如同 2和图 3所示, 眼内透镜 10包括布置于中部的光学体 30, 以及, 支撑体 20布置于光学体 30周围用于承载光学体 30。 在本实施 例中光学体 30为圆形, 直径为约 5mm, 其圆心用 O示出。 支撑体 20总宽度 W为约 6mm, 总长度 L约为 10.8mm- l 1.3mm。  As shown in Fig. 2 and Fig. 3, the intraocular lens 10 includes an optical body 30 disposed at a central portion, and a support body 20 is disposed around the optical body 30 for carrying the optical body 30. In the present embodiment, the optical body 30 is circular, having a diameter of about 5 mm, and its center is shown by O. The support body 20 has a total width W of about 6 mm and a total length L of about 10.8 mm to 1.3 mm.
如图 2和图 3中所示, 本实施例中共设置 6个凸起 40, 凸起 40 为半球形, 其为实心结构, 与人工晶状体为一体成型。 凸起 40设置 在支撑体 20的前表面, 布置于光学体 30的周围, 而且与人工晶状体 光滑连接。 半球形凸起的直径为约 0.3mm至约 0.5mm。 6个凸起 40 围绕光学体 30分开布置, 关于光学体 30上下对称且左右对称, 以使 眼内透镜 10稳定支撑在虹膜 140的背面。  As shown in Fig. 2 and Fig. 3, a total of six protrusions 40 are provided in the embodiment, and the protrusions 40 are hemispherical, which is a solid structure and is integrally formed with the intraocular lens. The projections 40 are provided on the front surface of the support body 20, are disposed around the optical body 30, and are smoothly connected to the intraocular lens. The hemispherical projections have a diameter of from about 0.3 mm to about 0.5 mm. The six projections 40 are arranged separately around the optical body 30, and the optical body 30 is vertically symmetrical and bilaterally symmetrical so that the intraocular lens 10 is stably supported on the back surface of the iris 140.
如图 1所示, 本发明通过改变眼内透镜 10的前表面的结构, 设在 支撑体 20前表面上的凸起 40能够将眼内透镜 10的前表面支撑于虹膜 140的背面, 凸起 40的周围形成间隙 50, 有效减轻了房水由后房流向 前房的阻力, 因此改善了房水循环。  As shown in FIG. 1, the present invention is capable of supporting the front surface of the intraocular lens 10 on the back surface of the iris 140 by changing the structure of the front surface of the intraocular lens 10, and the protrusion 40 provided on the front surface of the support body 20 A gap 50 is formed around the 40, which effectively reduces the resistance of the aqueous humor from the posterior chamber to the front chamber, thereby improving the aqueous circulation.
实施例 1 采用软性材料, 来自杭州百康医用技术有限公司生产 的 PC-PRL (有晶体眼后房屈光晶体) 材料。 用该材料的比重与房水 比重一致, 制作的眼内透镜可以实现在眼内悬浮定心, 即, 在眼内为 " 0 " 重量, " 0 " 机械摩擦, 从而可以不依靠支撑维持其在眼内的稳 定。 比较例 Example 1 A soft material, PC-PRL (with a crystal eye posterior refractive crystal) material from Hangzhou Baikang Medical Technology Co., Ltd. was used. The specific gravity of the material is consistent with the specific gravity of the aqueous humor. The intraocular lens can be made to suspend the center of the eye, that is, in the eye, it is "0" weight, "0" mechanical friction, so that it can be maintained without relying on the support. Stable in the eye. Comparative example
请参见附图 4、 图 5和图 6示出的眼内透镜比较例, 示出一种常 规的眼内透镜 10'。  Referring to the comparative example of the intraocular lens shown in Figs. 4, 5 and 6, a conventional intraocular lens 10' is shown.
与实施例 1的区别在于, 如图 4-6所示, 该眼内透镜 10'的支撑体 The difference from Embodiment 1 is that the support of the intraocular lens 10' is as shown in Figs. 4-6.
20'的前表面没有围绕光学体 30'的周围设置如本发明的凸起 40。 The front surface of 20' is not provided with a projection 40 as in the present invention around the periphery of the optical body 30'.
如图 4所示, 该透镜 10'用于植入眼后房 1 10, 并布置于自然晶状 体 150的前表面。 由于眼内透镜 10'的前表面与虹膜 140的后表面的接 触部分趋于增加, 从而眼内透镜 10'的前表面趋于与虹膜 140的后表面 贴紧, 因此, 房水由后房流向前房的阻力增加。 第二实施例  As shown in Fig. 4, the lens 10' is used for implantation in the posterior chamber of the eye 1 10 and is disposed on the front surface of the natural lens 150. Since the contact portion of the front surface of the intraocular lens 10' with the rear surface of the iris 140 tends to increase, the front surface of the intraocular lens 10' tends to be in close contact with the rear surface of the iris 140, and therefore, the aqueous humor flows from the posterior chamber. The resistance of the anterior chamber increases. Second embodiment
本发明的第二实施例与上述第一实施例具有类似结构, 因此, 对 相似的特征不予重复说明。请参见附图 7, 其示出本实施例眼内透镜的 俯视示意图。 在本实施例中, 4个半球形凸起 40设置在支撑体 20的 前表面, 布置于圆形光学体 30 的周围, 关于光学体上下对称且左右 对称, 以使眼内透镜稳定支撑在虹膜背面。 第三实施例  The second embodiment of the present invention has a similar structure to the above-described first embodiment, and therefore, similar features will not be repeatedly described. Referring to Figure 7, there is shown a top plan view of the intraocular lens of the present embodiment. In this embodiment, four hemispherical protrusions 40 are disposed on the front surface of the support body 20, and are disposed around the circular optical body 30, and the optical body is vertically symmetrical and bilaterally symmetrical so that the intraocular lens is stably supported on the iris. back. Third embodiment
本发明的第三实施例与上述实施例具有类似结构, 因此, 对相似 的特征不予重复说明。  The third embodiment of the present invention has a similar structure to the above-described embodiment, and therefore, similar features will not be repeatedly described.
本发明可适用于其他种类的光学体结构的眼内透镜。 本实施例中 采用的是椭圆形光学体 30, 不同于常见的圆形光学体。 在图中示出椭 圆形光学体 30的圆心 0, 其为椭圆形光学体的长轴方向直径与短轴方 向直径之交点。  The present invention is applicable to intraocular lenses of other kinds of optical body structures. The elliptical optical body 30 is employed in this embodiment, unlike the conventional circular optical body. The center 0 of the elliptical optical body 30 is shown in the figure, which is the intersection of the major axis diameter and the minor axis diameter of the elliptical optical body.
请参见附图 8, 其示出本发明第三实施例眼内透镜的俯视示意图。 在本实施例中, 4个半球形凸起 40设置在支撑体 20的前表面, 布置 于椭圆形光学体 30的周围, 关于光学体上下对称且左右对称, 以使眼 内透镜稳定支撑在虹膜背面。 第四实施例 Referring to Figure 8, there is shown a top plan view of an intraocular lens of a third embodiment of the present invention. In the present embodiment, four hemispherical protrusions 40 are disposed on the front surface of the support body 20, and are disposed around the elliptical optical body 30, and the optical body is vertically symmetric and bilaterally symmetrical so that the intraocular lens is stably supported on the iris. back. Fourth embodiment
本发明的第四实施例与上述实施例具有类似结构, 因此, 对相似 的特征不予重复说明。请参见附图 9, 其示出本发明第四实施例眼内透 镜的俯视示意图。 在本实施例中, 6 个半球形凸起 40 设置在支撑体 20的前表面, 布置于椭圆形光学体 30的周围, 关于光学体上下对称 且左右对称, 以使眼内透镜稳定支撑在虹膜背面。  The fourth embodiment of the present invention has a similar structure to the above-described embodiment, and therefore, similar features will not be repeatedly described. Referring to Figure 9, there is shown a top plan view of an intraocular lens of a fourth embodiment of the present invention. In this embodiment, six hemispherical protrusions 40 are disposed on the front surface of the support body 20, and are disposed around the elliptical optical body 30. The optical body is vertically symmetrical and bilaterally symmetrical so that the intraocular lens is stably supported on the iris. back.
在了解本发明之后, 本领域技术人员容易对本发明实施例进行多 种改变。 例如, 改变支撑体 40的结构和光学体的形状及结构。 例如, 在支撑体 40上设置适当的小孔, 小孔可以是圆形但不限于圆形, 该小 孔的作用一方面是便于医生在手术时操作, 勾住小孔可以移动透镜到 合适位置。 另一方面, 小孔也可以减少透镜与自然晶状体的接触表面 积。 另外, 由于眼内水状液是随时不断地由后房通过瞳孔流向前房, 小孔的存在也有利于进一步保证水状液前流的通畅性。 Various modifications of the embodiments of the invention will be apparent to those skilled in the <RTIgt; For example, the structure of the support 40 and the shape and structure of the optical body are changed. For example, a suitable small hole is provided on the support body 40. The small hole may be circular but not limited to a circular shape. The small hole functions on the one hand for the doctor to operate during the operation, and the small hole can be used to move the lens to a suitable position. . On the other hand, the small holes can also reduce the contact surface area of the lens with the natural lens. In addition, since the aqueous liquid in the eye is continuously flowing from the posterior chamber to the anterior chamber through the pupil, the presence of the small hole is also advantageous for further ensuring the patency of the aqueous fluid forward.
因此, 以上列举的仅是本发明的具体实施例。 显然, 本发明不限 于以上实施例, 还可以有许多变化例, 对于其他可能的变化例不在此 详细说明。 本领域的普通技术人员能从本发明公开的内容直接导出或 联想到的所有变形, 均应认为是本发明的保护范围。 本发明由所附权 利要求限定。  Accordingly, the above list is merely illustrative of specific embodiments of the invention. Obviously, the present invention is not limited to the above embodiments, and many variations are possible, and other possible variations are not described in detail herein. All modifications that can be directly derived or conceived by those skilled in the art from the disclosure of the present invention are considered to be the scope of the present invention. The invention is defined by the appended claims.

Claims

权 利 要 求 书 Claim
1. 一种眼内透镜, 其包括光学体和支撑体, 所述光学体和支撑体 具有前表面和后表面, 其中, An intraocular lens comprising an optical body and a support body, the optical body and the support body having a front surface and a rear surface, wherein
于所述眼内透镜的前表面, 在靠近所述光学体边缘的支撑体处设 置多个凸起。  On the front surface of the intraocular lens, a plurality of protrusions are provided at a support close to the edge of the optical body.
2. 根据权利要求 1所述的眼内透镜, 其中所述的凸起与眼内透镜 一体成型, 并且所述的凸起具有光滑的曲面。 2. The intraocular lens according to claim 1, wherein the protrusion is integrally formed with an intraocular lens, and the protrusion has a smooth curved surface.
3. 根据权利要求 2所述的眼内透镜, 其中所述的凸起为从所述眼 内透镜前表面突出的半球形。 The intraocular lens according to claim 2, wherein the protrusion is a hemisphere protruding from a front surface of the intraocular lens.
4. 根据权利要求 3 所述的眼内透镜, 其中所述的半球形直径为 0.3〜0.5mm。 4. The intraocular lens according to claim 3, wherein the hemispherical diameter is 0.3 to 0.5 mm.
5. 根据权利要求 1-4中任一项所述的眼内透镜, 其中所述多个凸 起以能够为眼内透镜提供稳定支撑的方式围绕所述光学体分开布置。 The intraocular lens according to any one of claims 1 to 4, wherein the plurality of protrusions are arranged separately around the optical body in a manner capable of providing stable support for the intraocular lens.
6. 根据权利要求 5所述的眼内透镜, 其中共设置 4个所述凸起, 相对于所述光学体以上下对称且左右对称的方式分开布置。 6. The intraocular lens according to claim 5, wherein a total of four of the protrusions are disposed apart from each other in a manner of being vertically symmetrical and bilaterally symmetrical with respect to the optical body.
7. 根据权利要求 5所述的眼内透镜, 其中共设置 6个所述凸起, 相对于所述光学体以上下对称且左右对称的方式分开布置。 7. The intraocular lens according to claim 5, wherein a total of six of the protrusions are disposed apart from each other in a manner of being vertically symmetrical and bilaterally symmetrical with respect to the optical body.
8. 根据权利要求 5所述的眼内透镜,所述眼内透镜的材料为软性 材料, 其比重与房水比重一致。 8. The intraocular lens according to claim 5, wherein the material of the intraocular lens is a soft material whose specific gravity is consistent with the specific gravity of the aqueous humor.
9. 根据权利要求 1所述的眼内透镜, 其中所述光学体具有大致的 椭圆形状, 其长轴设置于水平方向, 以及短轴设置于竖直方向。 9. The intraocular lens according to claim 1, wherein the optical body has a substantially elliptical shape with a long axis disposed in a horizontal direction and a short axis disposed in a vertical direction.
PCT/CN2014/070528 2013-01-14 2014-01-13 Intraocular lens WO2014108100A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201310013796XA CN103006351A (en) 2013-01-14 2013-01-14 Intraocular lens
CN201310013796.X 2013-01-14

Publications (1)

Publication Number Publication Date
WO2014108100A1 true WO2014108100A1 (en) 2014-07-17

Family

ID=47955827

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2014/070528 WO2014108100A1 (en) 2013-01-14 2014-01-13 Intraocular lens

Country Status (2)

Country Link
CN (1) CN103006351A (en)
WO (1) WO2014108100A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3200725A4 (en) * 2014-10-03 2018-08-08 Smartech I LLC Improved intraocular lens
US10159562B2 (en) 2014-09-22 2018-12-25 Kevin J. Cady Intraocular pseudophakic contact lenses and related systems and methods
US10299910B2 (en) 2014-09-22 2019-05-28 Kevin J. Cady Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method
US10945832B2 (en) 2014-09-22 2021-03-16 Onpoint Vision, Inc. Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method
US11109957B2 (en) 2014-09-22 2021-09-07 Onpoint Vision, Inc. Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method
US11109958B2 (en) 2019-05-29 2021-09-07 Physiol Posterior chamber phakic intraocular lens
US11938018B2 (en) 2014-09-22 2024-03-26 Onpoint Vision, Inc. Intraocular pseudophakic contact lens (IOPCL) for treating age-related macular degeneration (AMD) or other eye disorders

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103006351A (en) * 2013-01-14 2013-04-03 杭州百康医用技术有限公司 Intraocular lens
KR101840612B1 (en) * 2014-07-25 2018-03-20 무사시노 렌즈 리서치, 아이엔씨. Phakic intraocular lens
CN109152658B (en) * 2016-05-25 2022-04-19 眼科技术公司 Collapsible chamber within a suspension system for an intraocular lens

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001049216A1 (en) * 1999-12-30 2001-07-12 Cumming J Stuart Intraocular lens for posterior vaulting
CN2596958Y (en) * 2003-02-21 2004-01-07 杭州百康医用技术有限公司 Intra ocular diopter lens
US20040085511A1 (en) * 2002-10-29 2004-05-06 Nidek Co., Ltd Intraocular lens
US20110144746A1 (en) * 2009-12-11 2011-06-16 Vanderbilt David P Intraocular Lens
CN102600502A (en) * 2012-03-16 2012-07-25 无锡蕾明视康科技有限公司 Dynamic zooming artificial lens and preparation method of dynamic zooming artificial lens
CN103006351A (en) * 2013-01-14 2013-04-03 杭州百康医用技术有限公司 Intraocular lens
CN203280539U (en) * 2013-01-14 2013-11-13 杭州百康医用技术有限公司 Intraocular lens

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5197981A (en) * 1992-04-23 1993-03-30 Alcon Surgical, Inc. Intraocular lens having haptic of specific curvature and proportion
US20030204253A1 (en) * 2002-04-30 2003-10-30 Patel Anilbhai S. Posterior chamber phakic lens
CN1933791A (en) * 2003-11-14 2007-03-21 乔治W·罗扎基斯 Posterior chamber phakic intraocular lens
US20070129800A1 (en) * 2005-12-07 2007-06-07 C&C Vision International Limited Hydrolic accommodating intraocular lens

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001049216A1 (en) * 1999-12-30 2001-07-12 Cumming J Stuart Intraocular lens for posterior vaulting
US20040085511A1 (en) * 2002-10-29 2004-05-06 Nidek Co., Ltd Intraocular lens
CN2596958Y (en) * 2003-02-21 2004-01-07 杭州百康医用技术有限公司 Intra ocular diopter lens
US20110144746A1 (en) * 2009-12-11 2011-06-16 Vanderbilt David P Intraocular Lens
CN102600502A (en) * 2012-03-16 2012-07-25 无锡蕾明视康科技有限公司 Dynamic zooming artificial lens and preparation method of dynamic zooming artificial lens
CN103006351A (en) * 2013-01-14 2013-04-03 杭州百康医用技术有限公司 Intraocular lens
CN203280539U (en) * 2013-01-14 2013-11-13 杭州百康医用技术有限公司 Intraocular lens

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10159562B2 (en) 2014-09-22 2018-12-25 Kevin J. Cady Intraocular pseudophakic contact lenses and related systems and methods
US10299910B2 (en) 2014-09-22 2019-05-28 Kevin J. Cady Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method
US10842614B2 (en) 2014-09-22 2020-11-24 Onpoint Vision, Inc. Intraocular pseudophakic contact lenses and related systems and methods
US10945832B2 (en) 2014-09-22 2021-03-16 Onpoint Vision, Inc. Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method
US11109957B2 (en) 2014-09-22 2021-09-07 Onpoint Vision, Inc. Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method
US11432921B2 (en) 2014-09-22 2022-09-06 Onpoint Vision, Inc. Intraocular pseudophakic contact lenses and related systems and methods
US11571293B2 (en) 2014-09-22 2023-02-07 Onpoint Vision, Inc. Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method
US11583386B2 (en) 2014-09-22 2023-02-21 Onpoint Vision, Inc. Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method
US11903818B2 (en) 2014-09-22 2024-02-20 Onpoint Vision, Inc. Intraocular pseudophakic contact lenses and related systems and methods
US11938018B2 (en) 2014-09-22 2024-03-26 Onpoint Vision, Inc. Intraocular pseudophakic contact lens (IOPCL) for treating age-related macular degeneration (AMD) or other eye disorders
EP3200725A4 (en) * 2014-10-03 2018-08-08 Smartech I LLC Improved intraocular lens
US11109958B2 (en) 2019-05-29 2021-09-07 Physiol Posterior chamber phakic intraocular lens

Also Published As

Publication number Publication date
CN103006351A (en) 2013-04-03

Similar Documents

Publication Publication Date Title
JP4234584B2 (en) Multifocal intraocular lens and method of making and using the same
WO2014108100A1 (en) Intraocular lens
JP5538420B2 (en) Haptic device for intraocular lens
CA2800217C (en) Pseudophakic accommodating intraocular lens
US7806930B2 (en) Device for attachment to a capsule in an eye
US9308082B2 (en) Ocular collar stent for treating narrowing of the irideocorneal angle
US20110313522A1 (en) Pseudophakic Accommodating Intraocular Lens
US20130184816A1 (en) Intraocular lens rings
KR20000069353A (en) Scleral prosthesis for treatment of presbyopia and other eye disorders
US10010405B2 (en) Haptic devices for intraocular lens
EP3171821B1 (en) Haptic devices for intraocular lens
CN205831963U (en) There is crystal camera oculi posterior artificial intraocular lenses
JP2020526235A (en) Adjustable lens without glasses
US10265161B2 (en) Ocular collar stent for treating narrowing of the irideocorneal angle
CN100502807C (en) Ametropia correcting glasses for eye of posterior chamber type lens
RU86462U1 (en) REAR CAMERA ELASTIC INTRAOCULAR LENS FOR AFACIA CORRECTION
CN203280538U (en) Intraocular lens
CN211583666U (en) Grooved hole type crystalline eye refractive artificial lens
US20180104047A1 (en) Accommodative intraocular lens that ejects post capsular opacification and self-centers
WO2014108101A1 (en) Intraocular lens
CN203280539U (en) Intraocular lens
CN219230268U (en) Posterior chamber type intraocular lens with lens
US11833029B2 (en) Intraocular optic assembly
AU2016233337A1 (en) Improved self-centering phakic refractive lenses with parachute design
WO2012167246A1 (en) Capsular opacification blocking lens

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14738202

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14738202

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 14738202

Country of ref document: EP

Kind code of ref document: A1